iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
16 hedge funds and large institutions have $9.52M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
0% more funds holding
Funds holding: 16 → 16 (0)
48% less capital invested
Capital invested by funds: $18.3M → $9.52M (-$8.81M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$606K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$437K |
| 3 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$126K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$31.1K |
| 5 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
+$198 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$7.84M |
| 2 |
Truist Financial
Charlotte,
North Carolina
|
-$3.6M |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$23K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$22.4K |
| 5 |
CA
CoreCap Advisors
Southfield,
Michigan
|
-$3K |
IEIH Hedge Fund Activity: Q1 2022 in Review
16 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q1 2022, worth a combined $9.52M — down 48% from $18.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IEIH positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $606K. The largest seller was Cetera Advisor Networks, cutting an estimated $7.84M.
- 16 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $9.52M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q1 2022, down 48% quarter-over-quarter.
- 4 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q1 2022 and 2 closed out, a net change of +2 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q1 2022 was Susquehanna International Group, an estimated $606K added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q1 2022 was Cetera Advisor Networks, an estimated $7.84M sold.
Based on aggregated 13F filings for Q1 2022.